Sorafenib and sunitinib. (Record no. 19055859)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01194 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515182111.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200912s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1549-490X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1634/theoncologist.2009-0088 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kim, AeRang |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20091216 |
245 00 - TITLE STATEMENT | |
Title | Sorafenib and sunitinib. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The oncologist |
Date of publication, distribution, etc. | Aug 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 800-5 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, N.I.H., Intramural; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzenesulfonates |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Interactions |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indoles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Niacinamide |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenylurea Compounds |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrroles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sorafenib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sunitinib |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Balis, Frank M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Widemann, Brigitte C |
773 0# - HOST ITEM ENTRY | |
Title | The oncologist |
Related parts | vol. 14 |
-- | no. 8 |
-- | p. 800-5 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1634/theoncologist.2009-0088">https://doi.org/10.1634/theoncologist.2009-0088</a> |
Public note | Available from publisher's website |
No items available.